Expected to boost the growth of the Global Dental Anesthesia Market at a CAGR of 5.80% during the forecast period 2022 to 2030.

Market Research Future (MRFR) has published a cooked research report on the “Global Dental Anesthesia Market” that contains the information from 2022 to 2030. The dental anesthesia market is expected to register a CAGR of 5.80% during the forecast period of 2022 to 2030.

MRFR recognizes the following companies as the key players in the Global Dental Anesthesia Market— Dentsply Sirona (US), Septodont, Inc. (France), Astrazeneca (UK), Primex Pharmaceuticals (Europe), 3m (US), Centrix, Inc (US), Cetylite, Inc (US), Crosstex International, Inc. (US), Dmg America (US), Henry Schein, Inc. (US), Patterson Companies, Inc. (US), Pierrel SPA (Italy) among others.

Market Highlights

The Dental Anesthesia Market is expected to register a CAGR of 5.80% during the forecast period and is expected to hit USD 2758 million by 2030.

Dental anesthetic is the substance that is being utilized by the dentist for partial or complete numbness of mouth and it is used to manage pain and anxiety in patients. Moreover, dental anesthesia is a reversible process of losing sensation induced by the drug known as anesthetics. Furthermore, this procedure is used to minimize preoperative or postoperative pain, diagnostic testing & examination, and better patient’s cooperation.

The high prevalence of dental diseases, increasing trend towards dental health check-up, growing geriatric population worldwide are the key factors fueling the growth of the global market of dental anesthesia. Additionally, with the introduction of new dental products, the dental anesthesia market is expected to grow further in the coming years. However, dearth of skilled anesthesiologists might restrain the market's growth in the forecast period.

Access full report @ https://www.marketresearchfuture.com/reports/dental-anesthesia-market-755

Segment Analysis

The global dental anesthesia market has been divided based on product type, mode of administration, technique, duration of action, end user and distribution channel.

• The market, based on product, has been segmented into lidocaine, mepivacaine, prilocaine, bupivacaine 0.5% with epinephrine1:200,000, Articaine and others.


• Based on mode of administration, the dental anesthesia market has been divided into maxillary, mandibular and others.


• Based on technique, the market of dental anesthesia has been divided into local infiltration, field block and nerve block.


• Based on duration of action, the market of dental anesthesia has been divided into short, medium, and long.


• Based on end user, the dental anesthesia market has been divided into hospital clinics, clinics and other.


• Based on end user, the market for dental anesthesia has been divided into pharmacies and drug stores, e-commerce and other.

Regional Analysis

The global dental anesthesia market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas market is further divided into two parts: North America and South America. The Europe market of dental anesthesia has been segmented into Western Europe and Eastern Europe. Western Europe is also further sub-segmented into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market of dental anesthesia in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific.

The Americas market of dental anesthesia is expected to dominate due to developed healthcare infrastructure, an increasing number of dental care procedures, and the presence of a large number of market players in the region and the availability of a large number of industry players. boosting the market.

Europe held a significant share in the global market of dental anesthesia. The increasing prevalence of oral diseases, advancements in medical technology, growing elderly population, and increasing demand for oral care procedures & cosmetic dentistry is driving the dental anesthesia market in Europe.

Asia-Pacific is expected to be the fastest-growing market for beauty devices, mainly due to the improvements in healthcare infrastructure & facilities in the region, and rising healthcare expenditure. Factors such growing tobacco consumption in the region further drives dental care procedures further boost the market in the Asia-Pacific region.

The dental anesthesia market in the Middle East & Africa is growing dramatically due to less availability of funds, expensive and unaffordable dental care, and limited medical facilities in the region. Furthermore, growing awareness among people regarding surgeries with comparatively fewer side effects will generate lucrative opportunities in the Middle East & Africa.

Key Findings of the Study

• The Global Dental Anesthesia Market is expected to reach USD 2758 million by 2030 at a CAGR of 5.80% during the forecast period.


• The Americas region accounted for the largest share of the global market, owing to the developed healthcare infrastructure, an increasing number of dental care procedures, and availability of a large number of industry players.


• Based on product type, lidocaine segment is expected to register the fastest growth at a CAGR of 5.83% during the forecast period.


• Based on mode of administration, maxillary segment is expected to register the fastest growth at a CAGR of 5.56% during the forecast period.


• Based on technique, local infiltration segment is expected to register the fastest growth at a CAGR of 5.66% during the forecast period.


• Based on duration of action, short segment is expected to register the fastest growth at a CAGR of 5.45% during the forecast period.


• Based on end user, clinics segment is expected to register the fastest growth at a CAGR of 5.50% during the forecast period


• Based on distribution channel, the other segment held the fastest growth at a CAGR of 5.46% during the forecast period.


• Some of the key players operating in the dental anesthesia market are Dentsply Sirona (US), Septodont, Inc. (France), AstraZeneca (UK), Primex Pharmaceuticals (Europe), 3m (US), Centrix, Inc (US), Cetylite, Inc (US), Crosstex International, Inc. (US), Dmg America (US), Henry Schein, Inc. (US), Patterson Companies, Inc. (US), Pierrel SPA (Italy).